|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 12 December 2006
doi: 10.1242/jcs.03307
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
1 Graduate Program in Molecular and Systems Pharmacology Emory University, Atlanta, GA 30322, USA
2 Department of Pharmacology, Emory University, Atlanta, GA 30322, USA
3 Biogen Idec, Inc., San Diego, CA 92122, USA
* Author for correspondence (e-mail: gpavlat{at}emory.edu)
Accepted 18 October 2006
Skeletal muscle regeneration depends on myoblast migration, differentiation and myofiber formation. Isoforms of the nuclear factor of activated T cells (NFAT) family of transcription factors display nonredundant roles in skeletal muscle. NFAT5, a new isoform of NFAT, displays many differences from NFATc1-c4. Here, we examine the role of NFAT5 in myogenesis. NFAT5+/- mice displayed a defect in muscle regeneration with fewer myofibers formed at early times after injury. NFAT5 has a muscle-intrinsic function because inhibition of NFAT5 transcriptional activity caused both a migratory and differentiation defect in cultured myoblasts. We identified Cyr61 as a target of NFAT5 signaling in skeletal muscle cells. Addition of Cyr61 to cells expressing inhibitory forms of NFAT5 rescued the migratory phenotype. These results demonstrate a role for NFAT5 in skeletal muscle cell migration and differentiation. Furthermore, as cell-cell interactions are crucial for myoblast differentiation, these data suggest that myoblast migration and differentiation are coupled and that NFAT5 is a key regulator.
Key words: Skeletal muscle, NFAT5, TonEBP, Myogenesis, Migration, Differentiation
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
M. S. Kwon, S. W. Lim, and H. M. Kwon Hypertonic Stress in the Kidney: A Necessary Evil Physiology, June 1, 2009; 24(3): 186 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Aramburu and C. Lopez-Rodriguez Brx Shines a Light on the Route from Hyperosmolarity to NFAT5 Sci. Signal., April 7, 2009; 2(65): pe20 - pe20. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Darbellay, S. Arnaudeau, S. Konig, H. Jousset, C. Bader, N. Demaurex, and L. Bernheim STIM1- and Orai1-dependent Store-operated Calcium Entry Regulates Human Myoblast Differentiation J. Biol. Chem., February 20, 2009; 284(8): 5370 - 5380. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Cowling, M. J. McGrath, M.-A. Nguyen, D. L. Cottle, A. J. Kee, S. Brown, J. Schessl, Y. Zou, J. Joya, C. G. Bonnemann, et al. Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy J. Cell Biol., December 16, 2008; 183(6): 1033 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Xu, C. C. L. Wong, E. H. Y. Tong, S. S. M. Chung, J. R. Yates III, Y. Yin, and B. C. B. Ko Phosphorylation by Casein Kinase 1 Regulates Tonicity-induced Osmotic Response Element-binding Protein/Tonicity Enhancer-binding Protein Nucleocytoplasmic Trafficking J. Biol. Chem., June 20, 2008; 283(25): 17624 - 17634. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. O'Connor, C. M. Steeds, R. W. Wiseman, and G. K. Pavlath Phosphocreatine as an energy source for actin cytoskeletal rearrangements during myoblast fusion J. Physiol., June 15, 2008; 586(12): 2841 - 2853. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Bryan, T. E. Walshe, D. C. Mitchell, J. S. Havumaki, M. Saint-Geniez, A. S. Maharaj, A. E. Maldonado, and P. A. D'Amore Coordinated Vascular Endothelial Growth Factor Expression and Signaling During Skeletal Myogenic Differentiation Mol. Biol. Cell, March 1, 2008; 19(3): 994 - 1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. J. van der Velden, A. M. W. J. Schols, J. Willems, M. C. J. M. Kelders, and R. C. J. Langen Glycogen Synthase Kinase 3 Suppresses Myogenic Differentiation through Negative Regulation of NFATc3 J. Biol. Chem., January 4, 2008; 283(1): 358 - 366. [Abstract] [Full Text] [PDF] |
||||